June 2019

ONCOLOGY

EPIGENETICS AND CANCER WITH ALI SHILATIFARD, PHD

Featuring: Ali Shilatifard, PhD

Episode Summary

For three decades, Ali Shilatifard, PhD, has dedicated his career to revealing the causes of childhood leukemia, providing detailed molecular insight into the role of epigenetics in cancer. He hopes his discoveries will lead to a super drug that could end childhood leukemia and other cancers.

Continuing Medical Education Credit

Physicians who listen to this podcast may claim continuing medical education credit after listening to an episode of this program.

This podcast was originally release via the Feinberg School of Medicine News Center in June 2019.
Ali Shilatifard, PhD
  • Chair, Department of Biochemistry & Molecular Genetics
  • Director, Simpson Querrey Center for Epigenetics
  • Robert Francis Furchgott Professor
  • Professor of Biochemistry & Molecular Genetics and Pediatrics
  • Leader, Cancer Epigenetics and Nuclear Dynamics Program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like